ArticleHuman vaccines & immunotherapeutics2026
Addressing HPV vaccine hesitancy and misinformation in India through public health communication strategies.
Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
India witnessed a significant step forward in cervical cancer prevention and human papillomavirus (HPV) vaccine coverage with the rollout of a nationwide free HPV vaccination drive aimed at vaccinating 14‑y‑old girls. However, the campaign's success rate can be significantly reduced if timely measures to tackle vaccine hesitancy and related misinformation are not taken into account. This commentary article discusses the effects of HPV vaccine misinformation, identifies global vaccine hesitancy factors, and highlights behavioral determinants affecting HPV vaccine hesitancy and its coverage in India. It identifies low awareness, misconceptions, sociocultural beliefs, stigma, safety concerns, weak injunctive norms, parental resistance, urban-rural disparities, and health system barriers as key challenges associated with vaccine hesitancy and low vaccine uptake among adolescents in India. Using an integrated Health Belief Model (HBM) and COM-B theoretical framework, it proposes a culturally sensitive, evidence-based multifactorial communication strategy focused on raising awareness, building trust, countering misinformation, capacity building of healthcare providers, and enhancing opportunities for the adoption of HPV preventive behavior. The commentary highlights the need to actively engage parents, adolescents, healthcare providers, educators, influencers, media, and community members to strengthen vaccine confidence, social norms, and support India's broader cervical cancer prevention goals in alignment with WHO's 90-70-90 targets by 2030.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.